View in EDS

1510TiPThe GATTO study: A phase I of the anti-EGFR tomuzotuximab (TO) in combination with the anti-MUC1 gatipotuzumab (GAT) in patients with EGFR positive solid tumors.

Saved in:
Bibliographic Details
Title: 1510TiPThe GATTO study: A phase I of the anti-EGFR tomuzotuximab (TO) in combination with the anti-MUC1 gatipotuzumab (GAT) in patients with EGFR positive solid tumors.
Authors: Garralda, E1 (AUTHOR), Hoef, M van2 (AUTHOR), Ochsenreither, S3 (AUTHOR), Gianni, L4 (AUTHOR), Lorusso, D5 (AUTHOR), Fiedler, W6 (AUTHOR), Keilholz, U7 (AUTHOR), Klinghammer, K8 (AUTHOR), Dicke, C9 (AUTHOR), Kebenko, M9 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 133285567
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1510TiPThe GATTO study: A phase I of the anti-EGFR tomuzotuximab (TO) in combination with the anti-MUC1 gatipotuzumab (GAT) in patients with EGFR positive solid tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Garralda%2C+E%22">Garralda, E</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoef%2C+M+van%22">Hoef, M van</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ochsenreither%2C+S%22">Ochsenreither, S</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gianni%2C+L%22">Gianni, L</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%22">Lorusso, D</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fiedler%2C+W%22">Fiedler, W</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keilholz%2C+U%22">Keilholz, U</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Klinghammer%2C+K%22">Klinghammer, K</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dicke%2C+C%22">Dicke, C</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kebenko%2C+M%22">Kebenko, M</searchLink><relatesTo>9</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133285567
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdy292.131
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: N.PAG
    Titles:
      – TitleFull: 1510TiPThe GATTO study: A phase I of the anti-EGFR tomuzotuximab (TO) in combination with the anti-MUC1 gatipotuzumab (GAT) in patients with EGFR positive solid tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garralda, E
      – PersonEntity:
          Name:
            NameFull: Hoef, M van
      – PersonEntity:
          Name:
            NameFull: Ochsenreither, S
      – PersonEntity:
          Name:
            NameFull: Gianni, L
      – PersonEntity:
          Name:
            NameFull: Lorusso, D
      – PersonEntity:
          Name:
            NameFull: Fiedler, W
      – PersonEntity:
          Name:
            NameFull: Keilholz, U
      – PersonEntity:
          Name:
            NameFull: Klinghammer, K
      – PersonEntity:
          Name:
            NameFull: Dicke, C
      – PersonEntity:
          Name:
            NameFull: Kebenko, M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 10
              Text: 2018 Supplement
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 29
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1